Activation of the AMPK/PGC-1α pathway has been shown to reduce inflammation and upregulate GLUT4 expression, thereby improving skeletal muscle glucose metabolism in T2DM rats [2, 42]. Here, SLC2A4 is linked to type 2 diabetes mellitus.